← Back to Search

Behavioural Intervention

Mobile Game System for Autism

N/A
Waitlist Available
Led By Dennis P Wall, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Parent or primary caregiver over 18 of a child with autism between ages of 2 and 8
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

Study Summary

This trial will test a game system that could be used to help kids with developmental delays, like autism.

Who is the study for?
This trial is for children aged 2-8 with autism and their neurotypical siblings or unrelated neurotypical controls of the same age. Participants must have a confirmed autism diagnosis using tools like MARA. Families should be able to play the game without physical, intellectual, language, or environmental limitations.Check my eligibility
What is being tested?
The study is examining a mobile game system designed as an educational and treatment tool for children with developmental delays such as autism. It aims to collect data that could help in measuring progress and developing new AI models.See study design
What are the potential side effects?
Since this trial involves a non-invasive mobile game system, there are no direct medical side effects expected from participation. However, monitoring will occur for any unexpected reactions related to gameplay.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and care for a child aged 2-8 with autism.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mobile Application Usage
Preliminary change in parent/caregiver reported socialization on the Vineland Adaptive Behavior Scales,2nd Edition (VABS-2) from baseline to week 12
Secondary outcome measures
Change in Emotion Recognition from baseline to week 12
Change in NIH-Emotion Toolbox from baseline to Week 12
Change in Parent Stress Index - Short Form (PSI-SF) from baseline to week 12
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Neurotypical Sibling Control GroupExperimental Treatment1 Intervention
Neurotypical control participants will receive the same mobile game system for 12 weeks and be asked to play a minimum of ten 90-second game sessions per week per child over 12 weeks. Research team will further require that at least three of these 10 weekly sessions with each child be with game decks displaying emotion.
Group II: Autism Case GroupExperimental Treatment1 Intervention
Autistic participants will receive mobile game system for 12 weeks and be asked to play a minimum of ten 90-second game sessions per week per child over 12 weeks. Research team will further require that at least three of these 10 weekly sessions with each child be with game decks displaying emotion.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,708 Total Patients Enrolled
33 Trials studying Autism Spectrum Disorder
3,797 Patients Enrolled for Autism Spectrum Disorder
National Library of Medicine (NLM)NIH
39 Previous Clinical Trials
107,183 Total Patients Enrolled
Dennis P Wall, PhDPrincipal InvestigatorAssociate Professor
5 Previous Clinical Trials
1,880 Total Patients Enrolled
5 Trials studying Autism Spectrum Disorder
1,880 Patients Enrolled for Autism Spectrum Disorder

Media Library

Mobile Game System for Potential Treatment of Developmental Delays (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04909710 — N/A
Autism Spectrum Disorder Research Study Groups: Autism Case Group, Neurotypical Sibling Control Group
Autism Spectrum Disorder Clinical Trial 2023: Mobile Game System for Potential Treatment of Developmental Delays Highlights & Side Effects. Trial Name: NCT04909710 — N/A
Mobile Game System for Potential Treatment of Developmental Delays (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04909710 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applicants aged 20 and above eligible for this trial?

"This clinical trial is open to children who are between the ages of 2 and 8."

Answered by AI

Who meets the criteria for eligibility to participate in this medical research?

"This research study is seeking 300 individuals with autism spectrum disorder ranging in age from 2 to 8. To be eligible, applicants must have a parent or primary caregiver over the legal age of 18 who can provide care for the child during this trial period."

Answered by AI

What is the intent of this trial's implementation?

"The purpose of this trial, to be assessed at Week 12, is to observe the preliminary fluctuations in parent/caregiver reported socialization on the VABS-2 from baseline. Secondary objectives involve a scrutiny of changes in emotion recognition (as evaluated by an image based task), variations measured using NIH's Emotion Toolbox for ages 3-7 and 8-12 respectively, as well as alterations in parental stress levels determined through PSI-SF scale scores between 36 -180."

Answered by AI

Are there any open slots in this experiment that participants can join?

"According to the latest updates on clinicaltrials.gov, this study is not presently recruiting participants. The trial was initially posted in November 1st 2022 and last amended May 26th 2021. However, there are many other trials that require volunteers at this moment with a total of 279 ongoing studies."

Answered by AI
~85 spots leftby Jun 2025